Dietary Nitrates and Vascular Function in Patients With Peripheral Artery Disease
2 other identifiers
interventional
21
1 country
1
Brief Summary
The overarching question addressed in the current project is: Does dietary nitrate supplementation (8 weeks) improve physiological function in patients with peripheral arterial disease (PAD)? The investigators will specifically address whether dietary nitrate supplementation enhances blood vessel function, blood pressure regulation, and exercise capacity. The proposed project uses an array of clearly defined measurements which will allow investigators to quantify blood vessel function (vasodilator responsiveness and arterial stiffness), blood pressure (variability and responsiveness to stress), and functional capacity before and after 8 weeks of dietary supplementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedFirst Posted
Study publicly available on registry
November 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2016
CompletedResults Posted
Study results publicly available
June 3, 2019
CompletedJune 3, 2019
February 1, 2019
2.7 years
October 28, 2013
October 9, 2018
February 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Vasodilator Capacity
Forearm and calf blood flow will be measured independently by venous occlusion plethysmography using mercury-in-silastic strain gauges. Plethysmographic measurements will be made at rest and following 5 minutes of ischemia (reactive hyperemia) of the distal limb (forearm and calf). Peak blood flow will be determined as the highest flow recorded during the post deflation period. Total blood flow will be measured as the area under the time-curve after resting flow is subtracted. Vascular conductance will be calculated using blood flow/mean arterial pressure (via finger plethysmograph).
Pre and post 8 weeks of dietary nitrate supplementation
Change in Arterial Stiffness
ECG gated arterial waveforms will be obtained via applanation tonometry from the carotid and femoral arteries. The pulse wave velocity (PWV; index of arterial stiffness) will be determined between the carotid and femoral measurement sites (cfPWV). The time (t) between the feet of recorded pressure waves will be determined as the mean of 10 consecutive cardiac cycles. PWV is calculated from the distance (D; meters) between measurement points and the measured time delay (t): PWV = D/Δt (m/s).
Pre and post 8 weeks of dietary nitrate supplementation
Change in Functional Capacity - Distance Walked in 6 Minutes
6-minute walk tests will be performed before and after treatment to assess functional capacity. The main comparisons will be changes distance walked in 6 minutes after 8 weeks of dietary nitrate supplementation.
Pre and post 8 weeks of dietary nitrate supplementation
Study Arms (2)
Sodium Nitrate
EXPERIMENTALSodium Nitrate (1g/day) for 8 weeks
Placebo capsule
PLACEBO COMPARATORMicrocrystalline cellulose (daily) for 8 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Documented peripheral artery disease
- Ankle-Brachial Index (ABI) \< or = to 0.90
You may not qualify if:
- Non-atherosclerotic vascular disease
- Critical limb ischemia
- Active ischemic ulceration
- Recent (within one year) revascularization
- Symptomatic coronary artery disease (angina pectoris)
- Heart failure
- Resting systolic blood pressure \> 180 mmHg or diastolic pressure \> 100 mmHg
- Hypotension (resting systolic BP \< 90 mmHg)
- Smoking or history of smoking within past one year
- Use of phosphodiesterase V inhibitor drugs
- Women with history of hormone replacement therapy within the past 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Iowalead
- American Heart Associationcollaborator
Study Sites (1)
University of Iowa
Iowa City, Iowa, 52242, United States
Related Publications (1)
Hughes WE, Treichler DP, Ueda K, Bock JM, Casey DP. Sodium nitrate supplementation improves blood pressure reactivity in patients with peripheral artery disease. Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):710-714. doi: 10.1016/j.numecd.2021.12.002. Epub 2021 Dec 8.
PMID: 35090799DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Darren P. Casey
- Organization
- University of Iowa
Study Officials
- PRINCIPAL INVESTIGATOR
Darren P Casey, Ph.D.
University of Iowa
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 28, 2013
First Posted
November 14, 2013
Study Start
November 1, 2013
Primary Completion
June 30, 2016
Study Completion
June 30, 2016
Last Updated
June 3, 2019
Results First Posted
June 3, 2019
Record last verified: 2019-02